Call for Abstract
Scientific Program
10th International Tissue Repair and Regeneration Congress, will be organized around the theme “Mounting Cavernously in the field of Tissue Repair and Regeneration”
Tissue Repair 2018 is comprised of 15 tracks and 113 sessions designed to offer comprehensive sessions that address current issues in Tissue Repair 2018 .
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Skin Tissue Repair
- Track 1-2Inflamation
- Track 1-3Bone regeneration and modern techniques
- Track 1-4Tissue dysfunction
- Track 1-5Effects of guided tissue regeneration
- Track 1-6Intervertebral discs repair
- Track 1-7Fibrogenesis & Tissue Repair
- Track 1-8Fibroblasts in myocardial infarction
- Track 1-9 Macrophages in Tissue Repair
- Track 1-10Dental and craniofacial regeneration
- Track 1-11 Periodontal Regeneration
- Track 1-12Hemostasis
- Track 2-1Stem cell Biology
- Track 2-2Induction of pluripotent stem cells
- Track 2-3Cancer Stem cell
- Track 2-4Stem Cells for Repair of Heart Tissue
- Track 2-5Adipose tissue science
- Track 2-6Mesenchymal stem cells
- Track 2-7Transdifferentiation of adult hematopoietic stem cells
- Track 2-8Stem cell for targeted treatment for osteoarthritis
- Track 2-9Tissue sarcoma
- Track 3-1Primary cell culture
- Track 3-2Preservation and storage
- Track 3-3Proembryonic stem cell research
- Track 3-4Cryopreservation
- Track 3-5Towards cell culture automatization
- Track 4-1Neuro Regeneration
- Track 4-2Liver Regeneration
- Track 4-3Bone Regeneration
- Track 4-4traumatic brain injury
- Track 4-5Alzheimer’s disease
- Track 4-6osteoarthritis rheumatoid arthritis
- Track 4-7Skin avulsion
- Track 5-1Pancreas Tissue engineering
- Track 5-2Cardiac Tissue engineering
- Track 5-3Cartilage Tissue engineering
- Track 5-4Bone Tissue Tissue engineering
- Track 5-5Liver Tissue Engineering
- Track 5-6Challenges in tissue engineering
- Track 5-7Vascular tissue engineering
- Track 5-8Tissue engineering via gene delivery
- Track 5-9Cryo tissue engineering and equipment design
- Track 5-10Biomechanical stimulation
- Track 5-11Cell-based tissue engineering and cell signaling
- Track 6-1Bio active glasses
- Track 6-2Metal based material
- Track 6-3Polymers
- Track 6-4Biomaterials for drug delivery
- Track 6-5Biodegradable hydrogel
- Track 6-6Biomimetic materials
- Track 6-7Biomaterials design and technology
- Track 6-8Scaffold designs
- Track 6-9Fabrication of scaffolds
- Track 6-103D scaffolds and models
- Track 6-11Surface ligands and molecular architecture
- Track 6-12Porous scaffolds
- Track 6-13Tissue Microarray
- Track 7-1Immunology and Regenerative medicine
- Track 7-2Cardiovascular Regenerative medicine
- Track 7-3Regenerative endodontics
- Track 7-4Collaborative capital efficient translation in regenerative medicine
- Track 7-5Ethics and applications of regenerative medicine
- Track 7-6Regenerative medicine business model
- Track 7-7Global market scenario of the Regenerative medicine
- Track 7-8Clinical trials and regenerative medicine
- Track 8-1Cardiac regeneration and therapeutics
- Track 8-2Drug reinforcement and dependence
- Track 8-3Regenerative therapeutics
- Track 8-4Regenerative injection therapy
- Track 8-5Liver regeneration and therapeutics
- Track 8-6Photodynamic therapy
- Track 8-7Functional regenerative recovery
- Track 9-1Organ donation
- Track 9-2Skin bank
- Track 9-3Clinical application of banked tissue
- Track 9-4Trends in biobanking and preanalytics
- Track 10-1Neuro degeneration
- Track 10-2Brain and Spinal cord injury
- Track 10-3Mesenchymal Stem Cells for Cell Therapy and Tissue Regeneration
- Track 10-4Stem Cells for Cell-Based Therapies
- Track 10-5Cell Replacement Therapy
- Track 10-6Oncology and Stem Cell Therapy
- Track 10-7Stem Cell Therapy in Clinical Trails
- Track 10-8Stem Cell Treatments
- Track 11-1 Bioartificial skin
- Track 11-2Bioartificial pancreas
- Track 11-3Vascular substitute for cardiovascular
- Track 11-4Cortical grafts
- Track 11-5Fibrous encapsulation
- Track 11-6Biodegradable conduit
- Track 12-1Metaplasia
- Track 12-2Neoplasia
- Track 12-3Transdifferentiation
- Track 12-4Multiple sclerosis
- Track 12-5Chronic obstructive pulmonary disease
- Track 12-6Fibrodysplasia ossificans progressiva
- Track 13-1Erythropoietin
- Track 13-2Fibroblast growth factor
- Track 13-3Hepatocytic growth factor
- Track 13-4Platelet-Derived Growth Factor
- Track 13-5Reepithelialization
- Track 13-6Matrix-bound growth factors
- Track 14-1Osteogenesis
- Track 14-2Osteoprogenitor
- Track 14-3Orthopedic Implants
- Track 14-4Cell defective bone site
- Track 14-5Gene activated matrices
- Track 14-6Synthetic cartilage
- Track 14-7Recombinant signaling molecules
- Track 14-8Solid free form fabrication of scaffolds
- Track 15-1Physical Therapy
- Track 15-2 cardiac rehabilitation practice
- Track 15-3Clinical grade biotherapies